| Literature DB >> 23253000 |
G W Don1, F Joseph, D S Celermajer, T J Corte.
Abstract
A patient with pulmonary arterial hypertension secondary to systemic sclerosis was successfully treated with sitaxentan prior to its worldwide withdrawal (because of hepatotoxicity concerns), but then ironically experienced acute hepatic dysfunction during substitute bosentan therapy, and was eventually stabilised on a phosphodiesterase-5 inhibitor.Entities:
Mesh：
Substances：
Year: 2012 PMID： 23253000 DOI： 10.1111/imj.12007
Source DB: PubMed Journal: Intern Med J ISSN： 1444-0903 Impact factor: 2.048